CompletedNot Applicable

Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia

Indonesia22 participantsStarted 2025-10-19

Plain-language summary

Methamphetamine use disorder (MUD) remains a major public health concern in Indonesia, with limited effective treatment options and high relapse rates. Theta Burst Stimulation (TBS) has emerged as a promising adjunctive intervention for reducing craving and improving clinical outcomes. This trial aims to evaluate the efficacy and safety of TBS for MUD. A RCT of 20 subjects was conducted to evalute the efficacy and safety of TBS as an adjunctive treatment to CBT in managing MUD.

Who can participate

Age range18 Years – 59 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects aged 18-59 years old * Subjects diagnosed with methamphetamine use disorder without having undergone treatment, whether psychotherapy and/or psychopharmacological modalities * Subjects are able to read and write Exclusion Criteria: * Subjects with severe thought process disorders, impaired perception, restless condition, severe neurological disorders, history of neuromodulation, * Subjects refused to participate in the study * Subjects who are pregnant * Subjects who have radioactive implants

What they're measuring

Improvement in craving for methamphetamine

Timeframe: Baseline (T1), day 3 (T2), day 5 (T3), day 8 (T4), and day 10 (T5)

Improvement in craving (tonic) for methamphetamine

Timeframe: Baseline (T1), day 3 (T2), day 5 (T3), day 8 (T4), and day 10 (T5)

Improvement in clinical severity

Timeframe: Baseline (T1), day 3 (T2), day 5 (T3), day 8 (T4), and day 10 (T5)

Trial details

NCT IDNCT07399431

SponsorIndonesia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-03

View on ClinicalTrials.gov More Methamphetamine Use Disorder trials